Experience in Using Hypercvad Combined With Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms

Blood - United States
doi 10.1182/blood.v112.11.5013.5013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Nk/T-Cell Lymphoma, the French Experience.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas With Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified

Clinical Cancer Research
Cancer ResearchOncology
2004English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Autologous Peripheral Blood Hematopoietic Cell Transplantation in Dogs With T-Cell Lymphoma

Journal of Veterinary Internal Medicine
MedicineVeterinary
2014English

Peripheral T Cell Lymphoma Presenting With Hypereosinophilia

Medical Journal Armed Forces India
Medicine
2008English

Extranodal NK/T Cell Lymphoma, Nasal Type

Trends in General Practice
2018English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports
Medicine
2018English

Peripheral T-Cell Tolerance in Hosts With Acute Myeloid Leukemia

OncoImmunology
OncologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy